BASIL-2 points towards endovascular-first revascularisation strategy in CLTI patients @VascularNews

In the BASIL-2 (Bypass versus angioplasty for severe ischaemia of the leg) trial of 345 patients with chronic limb-threatening ischaemia (CLTI), a best endovascular treatment-first revascularisation strategy was associated with better amputation-free survival than a vein bypass-first strategy in those who required an infrapopliteal repair—with or without a more proximal infrainguinal procedure. This result was... Continue Reading →

Up ↑

Verified by MonsterInsights